As Americans clamor for COVID-19 shots that can’t seem to be produced quickly enough, Emergent BioSolutions will face its first test. Source
As Americans clamor for COVID-19 shots that can’t seem to be produced quickly enough, Emergent BioSolutions will face its first test. Source